# DUAC® Early Onset Efficacy Study in Japanese Subjects

> **NCT02557399** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 350 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Duac® fixed dose combination gel
- **DRUG:** ADA 0.1% gel
- **DRUG:** CLDM 1% gel

## Key facts

- **NCT ID:** NCT02557399
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-07
- **Primary completion:** 2015-12-17
- **Final completion:** 2016-02-17
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2018-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02557399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02557399, "DUAC® Early Onset Efficacy Study in Japanese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02557399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*